Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients with Hypertrophic Cardiomyopathy

American Journal of Cardiology

Volumn 116, Issue 3, 2015, Pages 436-441

  Chan, Raymond H ^a,b   Maron, Barry J ^c   Olivotto, Iacopo ^d   Assenza, Gabriele E ^e   Haas, Tammy S ^c   Lesser, John R ^c   Gruner, Christiane ^a,f   Crean, Andrew M ^a   Rakowski, Harry ^a   Rowin, Ethan ^g   Udelson, James ^g   Lombardi, Massimo ^h   Tomberli, Benedetta ^d   Spirito, Paolo ⁱ   Formisano, Francesco ⁱ   Marra, Martina P ^j   Biagini, Elena ^k   Autore, Camillo ^e   Manning, Warren J ^b   Appelbaum, Evan ^b   Roberts, William C ^l   Basso, Cristina ^j   Maron, Martin S ^g   more..

^a TORONTO GENERAL HOSPITAL   (Canada)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f University Hospital   (Switzerland)

^g TUFTS MEDICAL CENTER   (United States)

^h IRCCS POLICLINICO SAN DONATO   (Italy)

ⁱ GALLIERA HOSPITAL   (Italy)

^j UNIVERSITY OF PADOVA   (Italy)

^k UNIVERSITY OF BOLOGNA   (Italy)

^l BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; AGED; ARTICLE; CONTRAST ENHANCEMENT; EXTRACELLULAR SPACE; FEMALE; HAZARD RATIO; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE; HEART VENTRICLE SEPTUM; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUSCLE CELL; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCAR FORMATION; VERY ELDERLY; ADOLESCENT; CARDIOMYOPATHY, HYPERTROPHIC; CLINICAL TRIAL; DIAGNOSTIC USE; FOLLOW UP; HEART VENTRICLE; IMAGE ENHANCEMENT; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; RETROSPECTIVE STUDY; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM; HEART VENTRICLES; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TIME FACTORS; VENTRICULAR SEPTUM; YOUNG ADULT;

EID: 84937518823     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.04.060     Document Type: Article

References (28)

1. R.H. Chan, B.J. Maron, I. Olivotto, M.J. Pencina, G.E. Assenza, T. Haas, J.R. Lesser, C. Gruner, A.M. Crean, H. Rakowski, J.E. Udelson, E. Rowin, M. Lombardi, F. Cecchi, B. Tomberli, P. Spirito, F. Formisano, E. Biagini, C. Rapezzi, C.N. De Cecco, C. Autore, E.F. Cook, S.N. Hong, C.M. Gibson, W.J. Manning, E. Appelbaum, and M.S. Maron Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy Circulation 130 2014 484 495
2. R. O'Hanlon, A. Grasso, M. Roughton, J.C. Moon, S. Clark, R. Wage, J. Webb, M. Kulkarni, D. Dawson, L. Sulaibeekh, B. Chandrasekaran, C. Bucciarelli-Ducci, F. Pasquale, M.R. Cowie, W.J. McKenna, M.N. Sheppard, P.M. Elliott, D.J. Pennell, and S.K. Prasad Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 867 874
3. O. Bruder, A. Wagner, C.J. Jensen, S. Schneider, P. Ong, E.M. Kispert, K. Nassenstein, T. Schlosser, G.V. Sabin, U. Sechtem, and H. Mahrholdt Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 875 887
4. J.J. Green, J.S. Berger, C.M. Kramer, and M. Salerno Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy JACC Cardiovasc Imaging 5 2012 370 377
5. J.C. Moon, W.J. McKenna, J.A. McCrohon, P.M. Elliott, G.C. Smith, and D.J. Pennell Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 2003 1561 1567
6. R. Rubinshtein, J.F. Glockner, S.R. Ommen, P.A. Araoz, M.J. Ackerman, P. Sorajja, J.M. Bos, A.J. Tajik, U.S. Valeti, R.A. Nishimura, and B.J. Gersh Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy Circ Heart Fail 3 2010 51 58
7. C.E. Rochitte, E.M. Tassi, and A.A. Shiozaki The emerging role of MRI in the diagnosis and management of cardiomyopathies Curr Cardiol Rep 8 2006 44 52
8. J.C. Moon, and W.J. McKenna The emerging role of cardiovascular magnetic resonance in refining the diagnosis of hypertrophic cardiomyopathy Nat Clin Pract Cardiovasc Med 6 2009 166 167
9. D.J. Pennell Cardiovascular magnetic resonance Circulation 121 2010 692 705
10. M.S. Maron Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Cardiovasc Magn Reson 14 2012 13
11. L. Choudhury, H. Mahrholdt, A. Wagner, K.M. Choi, M.D. Elliott, F.J. Klocke, R.O. Bonow, R.M. Judd, and R.J. Kim Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy J Am Coll Cardiol 40 2002 2156 2164
12. B.J. Gersh, B.J. Maron, R.O. Bonow, J.A. Dearani, M.A. Fifer, M.S. Link, S.S. Naidu, R.A. Nishimura, S.R. Ommen, H. Rakowski, C.E. Seidman, J.A. Towbin, J.E. Udelson, and C.W. Yancy 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 124 2011 2761 2796
13. B.J. Maron, W.J. McKenna, G.K. Danielson, L.J. Kappenberger, H.J. Kuhn, C.E. Seidman, P.M. Shah, W.H. Spencer 3rd, P. Spirito, F.J. Cate Ten, E.D. Wigle Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology Clinical Expert Consensus Document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713
14. B.J. Maron, S.R. Ommen, C. Semsarian, P. Spirito, I. Olivotto, and M.S. Maron Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine J Am Coll Cardiol 64 2014 83 99
15. B.J. Maron, and M.S. Maron Hypertrophic cardiomyopathy Lancet 381 2013 242 255
16. K.M. Harris, P. Spirito, M.S. Maron, A.G. Zenovich, F. Formisano, J.R. Lesser, S. Mackey-Bojack, W.J. Manning, J.E. Udelson, and B.J. Maron Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy Circulation 114 2006 216 225
17. M.D. Cerqueira, N.J. Weissman, V. Dilsizian, A.K. Jacobs, S. Kaul, W.K. Laskey, D.J. Pennell, J.A. Rumberger, T. Ryan, and M.S. Verani Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 2002 539 542
18. T. Kuribayashi, and W.C. Roberts Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy Am J Cardiol 70 1992 1333 1340
19. D.H. Kwon, R.M. Setser, Z.B. Popovic, M. Thamilarasan, S. Sola, P. Schoenhagen, M.J. Garcia, S.D. Flamm, H.M. Lever, and M.Y. Desai Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study Int J Cardiovasc Imaging 24 2008 617 625
20. C. Basso, G. Thiene, D. Corrado, G. Buja, P. Melacini, and A. Nava Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia Hum Pathol 31 2000 988 998
21. K.G. Blyth, B.A. Groenning, T.N. Martin, J.E. Foster, P.B. Mark, H.J. Dargie, and A.J. Peacock Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension Eur Heart J 26 2005 1993 1999
22. B.J. Maron, and W.C. Roberts Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy Circulation 59 1979 689 706
23. B.J. Maron, T.J. Anan, and W.C. Roberts Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy Circulation 63 1981 882 894
24. J. Shirani, R. Pick, W.C. Roberts, and B.J. Maron Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death J Am Coll Cardiol 35 2000 36 44
25. J.C.C. Moon, E. Reed, M.N. Sheppard, A.G. Elkington, S.Y. Ho, M. Burke, M. Petrou, and D.J. Pennell The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 43 2004 2260 2264
26. R.J. Kim, and R.M. Judd Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy J Am Coll Cardiol 41 2003 1568 1572
27. T. Papavassiliu, P. Schnabel, M. Schröder, and M. Borggrefe CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis Eur Heart J 26 2005 2395
28. G. Moravsky, E. Ofek, H. Rakowski, J. Butany, L. Williams, A. Ralph-Edwards, B.J. Wintersperger, and A. Crean Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR JACC Cardiovasc Imaging 6 2013 587 596